Assenagon Asset Management’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.3M | Buy |
1,103,075
+689,561
| +167% | +$10.2M | 0.02% | 360 |
|
|
2025
Q1 | $7.41M | Sell |
413,514
-116,999
| -22% | -$2.1M | 0.01% | 455 |
|
|
2024
Q4 | $9.24M | Sell |
530,513
-844,009
| -61% | -$14.7M | 0.01% | 513 |
|
|
2024
Q3 | $19.2M | Sell |
1,374,522
-839,577
| -38% | -$11.7M | 0.04% | 332 |
|
|
2024
Q2 | $18.2M | Buy |
2,214,099
+1,995,419
| +912% | +$16.4M | 0.04% | 288 |
|
|
2024
Q1 | $1.69M | Sell |
218,680
-35,371
| -14% | -$273K | ﹤0.01% | 921 |
|
|
2023
Q4 | $2.28M | Hold |
254,051
| – | – | 0.01% | 844 |
|
|
2023
Q3 | $2.27M | Sell |
254,051
-843,994
| -77% | -$7.55M | 0.01% | 787 |
|
|
2023
Q2 | $16.9M | Sell |
1,098,045
-560,644
| -34% | -$8.61M | 0.06% | 239 |
|
|
2023
Q1 | $37.3M | Buy |
1,658,689
+791,270
| +91% | +$17.8M | 0.13% | 124 |
|
|
2022
Q4 | $18.2M | Sell |
867,419
-57,095
| -6% | -$1.2M | 0.07% | 236 |
|
|
2022
Q3 | $22.8M | Sell |
924,514
-25,951
| -3% | -$639K | 0.09% | 207 |
|
|
2022
Q2 | $23M | Buy |
950,465
+639,114
| +205% | +$15.5M | 0.09% | 188 |
|
|
2022
Q1 | $8.02M | Buy |
311,351
+115,820
| +59% | +$2.98M | 0.02% | 394 |
|
|
2021
Q4 | $6.07M | Buy |
+195,531
| New | +$6.07M | 0.02% | 431 |
|
|
2020
Q4 | – | Sell |
-359,761
| Closed | -$6.64M | – | 1223 |
|
|
2020
Q3 | $6.64M | Buy |
359,761
+195,592
| +119% | +$3.61M | 0.04% | 236 |
|
|
2020
Q2 | $3.35M | Sell |
164,169
-266,277
| -62% | -$5.44M | 0.02% | 413 |
|
|
2020
Q1 | $6.28M | Buy |
+430,446
| New | +$6.28M | 0.05% | 175 |
|
|
2019
Q1 | – | Sell |
-21,808
| Closed | -$494K | – | 1077 |
|
|
2018
Q4 | $494K | Buy |
+21,808
| New | +$494K | 0.01% | 779 |
|